Australia markets closed

Inovio Pharmaceuticals, Inc. (INO)

NasdaqGS - NasdaqGS Delayed price. Currency in USD
Add to watchlist
20.71+0.38 (+1.88%)
As of 12:24PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close20.33
Open20.18
Bid20.65 x 800
Ask20.72 x 1300
Day's range19.95 - 20.78
52-week range1.92 - 33.79
Volume3,951,357
Avg. volume35,615,171
Market cap3.275B
Beta (5Y monthly)1.31
PE ratio (TTM)N/A
EPS (TTM)-1.16
Earnings date10 Aug 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est22.33
  • 3 Most Popular Coronavirus Stocks on Robinhood: Are They Buys?
    Motley Fool

    3 Most Popular Coronavirus Stocks on Robinhood: Are They Buys?

    Robinhood investors like two fast-growing biotechs and one big pharma company that each have promising COVID-19 vaccine candidates.

  • Better Coronavirus Stock: Inovio Pharmaceuticals or VBI Vaccines?
    Motley Fool

    Better Coronavirus Stock: Inovio Pharmaceuticals or VBI Vaccines?

    Inovio Pharmaceuticals (NASDAQ: INO) is enjoying its best stock performance in seven years thanks to investors' interest in its novel coronavirus vaccine program. VBI Vaccines (NASDAQ: VBIV) appears to be on track for its best year ever -- for the same reason. There are currently 25 COVID-19 vaccine candidates in clinical testing across the world.

  • Better Coronavirus Stock: Pfizer or Inovio Pharmaceuticals?
    Motley Fool

    Better Coronavirus Stock: Pfizer or Inovio Pharmaceuticals?

    There are no signs the coronavirus pandemic is slowing down in the U.S., with more than 1,100 Americans dying every day from COVID-19 in recent days. Beyond the staggering fatalities, one estimate by the Australian National University puts the virus' potential global economic damage at over $21 trillion. The need for a coronavirus vaccine has thus become paramount to saving lives and mitigating economic catastrophes.